Many studies have reported that RGS4 is associated with increased cancer cell viability, invasion, and/or motility in glioma [49], triple-negative breast cancer [47], etc. However, the role of RGS4 remains poorly understood in ES, and the related mechanism remains to be further explored. This evidence concerns the gene RGS4 and triple-negative breast carcinoma.